We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STKL
1151
DELISTED
SunOpta
STKL
| $67K | ﹤0.01% |
5,760
-1,039
| -15% | -$9.15K |
|
|
FOLD
1152
DELISTED
Amicus Therapeutics
FOLD
| $66K | ﹤0.01% |
2,894
| – | – |
|
1153
InterDigital
IDCC
$8.89B
| $66K | ﹤0.01% |
1,100
+297
| +37% | +$17.8K |
|
|
SEM
1154
DELISTED
Select Medical
SEM
| $66K | ﹤0.01% |
4,451
+654
| +17% | +$8.54K |
|
|
MORF
1155
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $66K | ﹤0.01% |
+1,974
| New | +$58.3K |
|
|
LL
1156
DELISTED
LL Flooring Holdings, Inc.
LL
| $66K | ﹤0.01% |
+2,176
| New | +$60.5K |
|
|
MDC
1157
DELISTED
M.D.C. Holdings, Inc.
MDC
| $66K | ﹤0.01% |
1,481
-394
| -21% | -$17.6K |
|
|
GBT
1158
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $66K | ﹤0.01% |
+1,539
| New | +$75.9K |
|
1159
Navient
NAVI
$853M
| $65K | ﹤0.01% |
6,707
+4,449
| +197% | +$42.3K |
|
|
GTS
1160
DELISTED
Triple-S Management Corporation
GTS
| $65K | ﹤0.01% |
+3,072
| New | +$65.6K |
|
1161
Ingles Markets
IMKTA
$1.67B
| $64K | ﹤0.01% |
1,516
+14
| +0.9% | +$541 |
|
1162
RB Global
RBA
$17.5B
| $64K | ﹤0.01% |
932
+110
| +13% | +$7.28K |
|
|
QVCGA
1163
DELISTED
QVC Group Inc Series A
QVCGA
| $64K | ﹤0.01% |
117
+47
| +67% | +$21.2K |
|
1164
Alcon
ALC
$35B
| $63K | ﹤0.01% |
958
-140,593
| -99% | -$8.8M |
|
|
JNPR
1165
DELISTED
Juniper Networks
JNPR
| $63K | ﹤0.01% |
2,813
-148,145
| -98% | -$3.23M |
|
1166
Schrodinger
SDGR
$1.36B
| $63K | ﹤0.01% |
+808
| New | +$50.8K |
|
1167
Globant
GLOB
$1.61B
| $62K | ﹤0.01% |
288
-31
| -10% | -$5.99K |
|
1168
Jazz Pharmaceuticals
JAZZ
$16.7B
| $62K | ﹤0.01% |
377
| – | – |
|
1169
Patrick Industries
PATK
$2.95B
| $62K | ﹤0.01% |
+1,379
| New | +$58.5K |
|
1170
Scansource
SCSC
$1.12B
| $62K | ﹤0.01% |
2,376
+934
| +65% | +$22.4K |
|
|
WWE
1171
DELISTED
World Wrestling Entertainment
WWE
| $62K | ﹤0.01% |
1,299
-632
| -33% | -$26.5K |
|
1172
Future Fuel
FF
$223M
| $61K | ﹤0.01% |
+4,830
| New | +$58.3K |
|
1173
Progress Software
PRGS
$1.76B
| $61K | ﹤0.01% |
1,355
-38,794
| -97% | -$1.57M |
|
|
KE
1174
Kimball Electronics
KE
$628M
| $60K | ﹤0.01% |
3,784
+1,714
| +83% | +$24.3K |
|
1175
Kelly Services Class A
KELYA
$527M
| $60K | ﹤0.01% |
2,960
| – | – |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.